載入...

Outcomes analysis in patients with extended-spectrum beta-lactamase bacteremia empirically treated with piperacillin/tazobactam versus carbapenems

Infections caused by extended-spectrum beta-lactamase (ESBL)-producing bacteria are associated with worse outcomes and have limited treatment options. Carbapenems remain the drug of choice for these infections due to evidence of a mortality benefit and the mixed clinical efficacy associated with pip...

全面介紹

Na minha lista:
書目詳細資料
發表在:Proc (Bayl Univ Med Cent)
Main Authors: John, Reeba, Colley, Peter, Nguyen, Hoa L., Berhe, Mezgebe
格式: Artigo
語言:Inglês
出版: Taylor & Francis 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6541085/
https://ncbi.nlm.nih.gov/pubmed/31191124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2019.1582466
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!